Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 5-6/2018

12.09.2017 | original article

Radial versus femoral access site for percutaneous coronary intervention in patients suffering acute myocardial infarction

A randomized prospective multicenter trial

verfasst von: MD Christiana Schernthaner, MD Matthias Hammerer, MD Stefan Harb, MD Matthias Heigert, MD Kurt Hoellinger, Elisabeth Lassnig, MD Edwin Maurer, MD Jochen Schuler, MD Peter Siostrzonek, MD Hanno Ulmer, MD Andreas Winter, MD Johann Altenberger

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 5-6/2018

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Transradial access (TRA) in percutaneous coronary intervention (PCI) is a widely used standard technique with lower complication rates compared to transfemoral access (TFA). The aim of this study was to evaluate the impact of TRA versus TFA for PCI on clinically significant vascular access complications in the setting of acute myocardial infarction (AMI).

Methods

This multicenter study randomly assigned 250 patients in a 1:1 fashion (TRA vs. TFA) admitted with or without ST-segment elevation AMI undergoing immediate PCI. The primary endpoint was defined as the occurrence of hematoma, pseudo-aneurysm or local bleeding at the access site requiring any further intervention and/or prolonged hospital stay. Radiation exposure to the patient and operator was also investigated.

Results

In the study cohort (N = 250 patients, mean age 62 ± 12.7 years, 76% males) 5 patients (2%) achieved the primary endpoint without a significant difference between groups, 4 out of 125 (3.2%) in the TFA group and 1 out of 125 (0.8%) in the TRA group (p = 0.17). Access site hematoma was significantly more frequent in the TFA group compared to the TRA group (24.8% vs. 8.8%, respectively; p < 0.0007). Local bleeding was only seen in the TFA group (3.2% vs. 0%, p = 0.04). Time intervals from admission to catheter laboratory to first balloon inflation were longer in the TRA compared to the TFA group (34 ± 17 min vs 29.5 ± 13 min, respectively; p = 0.018). Radiation exposure to the patient and operator was identical.

Conclusion

The use of TRA was accompanied by lower rates of access site complications; however, the need for subsequent treatment or prolonged hospital stays was not observed using either of the two access approaches.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Azzalini L, Khan R, Al-Hawwas M, Hatem R, Fortier A, L’Allier PL, Ly HQ. Effect of radial-to-femoral access crossover on adverse outcomes in primarypercutaneous coronary intervention. Am J Cardiol. 2014;114:1165–73. CrossRefPubMed Azzalini L, Khan R, Al-Hawwas M, Hatem R, Fortier A, L’Allier PL, Ly HQ. Effect of radial-to-femoral access crossover on adverse outcomes in primarypercutaneous coronary intervention. Am J Cardiol. 2014;114:1165–73. CrossRefPubMed
2.
Zurück zum Zitat Valgimigli M, Gagnor A, Calabró P, Frigoli E, Leonardi S, Zaro T, MATRIX Investigators, Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomized multicentre trial. Lancet. 2015;385:2465–76. CrossRefPubMed Valgimigli M, Gagnor A, Calabró P, Frigoli E, Leonardi S, Zaro T, MATRIX Investigators, Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomized multicentre trial. Lancet. 2015;385:2465–76. CrossRefPubMed
3.
Zurück zum Zitat Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, RIVAL trial group, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377:1409–20. Erratum in: Lancet. 2011;378(9785):30. Lancet. 2011 ;377(9775):1408. CrossRefPubMed Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, RIVAL trial group, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377:1409–20. Erratum in: Lancet. 2011;378(9785):30. Lancet. 2011 ;377(9775):1408. CrossRefPubMed
4.
Zurück zum Zitat Mehta SR, Jolly SS, Cairns J, Niemela K, Rao SV, Cheema AN, RIVAL Investigators, et al. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Collcardiol. 2012;60:2490–9. CrossRef Mehta SR, Jolly SS, Cairns J, Niemela K, Rao SV, Cheema AN, RIVAL Investigators, et al. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Collcardiol. 2012;60:2490–9. CrossRef
5.
Zurück zum Zitat Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60:2481–9. CrossRefPubMed Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012;60:2481–9. CrossRefPubMed
6.
Zurück zum Zitat Bernat I, Horak D, Stasek J, Mates M, Pesek J, Ostadal P. et al ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial. J Am Coll Cardiol. 2014;63:964–72. CrossRefPubMed Bernat I, Horak D, Stasek J, Mates M, Pesek J, Ostadal P. et al ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial. J Am Coll Cardiol. 2014;63:964–72. CrossRefPubMed
7.
Zurück zum Zitat Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, et al. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart. 2008;94:1019–25. CrossRefPubMed Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, et al. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart. 2008;94:1019–25. CrossRefPubMed
8.
Zurück zum Zitat Ratib K, Mamas MA, Anderson SG, Bhatia G, Routledge H, De Belder M, British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research, et al. Access site practice and procedural outcomes in relation to clinical presentation in 439,947 patients undergoing percutaneous coronary intervention in the United Kingdom. JACC Cardiovasc Interv. 2015;8:20–9. CrossRefPubMed Ratib K, Mamas MA, Anderson SG, Bhatia G, Routledge H, De Belder M, British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research, et al. Access site practice and procedural outcomes in relation to clinical presentation in 439,947 patients undergoing percutaneous coronary intervention in the United Kingdom. JACC Cardiovasc Interv. 2015;8:20–9. CrossRefPubMed
9.
Zurück zum Zitat Valgimigli M, Saia F, Guastaroba P, Menozzi A, Magnavacchi P, Santarelli A, REAL Registry Investigators, et al. Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistroregionaleAngiopLastichedell’Emilia-Romagna) multicenter registry. JACC Cardiovasc Interv. 2012;5:23–35. CrossRefPubMed Valgimigli M, Saia F, Guastaroba P, Menozzi A, Magnavacchi P, Santarelli A, REAL Registry Investigators, et al. Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistroregionaleAngiopLastichedell’Emilia-Romagna) multicenter registry. JACC Cardiovasc Interv. 2012;5:23–35. CrossRefPubMed
10.
Zurück zum Zitat Agostoni P, Biondi-Zoccai GG, de Benedictis ML, Rigattieri S, Turri M, Anselmi M, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44:349–56. Review. CrossRefPubMed Agostoni P, Biondi-Zoccai GG, de Benedictis ML, Rigattieri S, Turri M, Anselmi M, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44:349–56. Review. CrossRefPubMed
11.
Zurück zum Zitat Joyal D, Bertrand OF, Rinfret S, Shimony A, Eisenberg MJ. Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention. Am J Cardiol. 2012;109:813–8. CrossRefPubMed Joyal D, Bertrand OF, Rinfret S, Shimony A, Eisenberg MJ. Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention. Am J Cardiol. 2012;109:813–8. CrossRefPubMed
12.
Zurück zum Zitat Vranckx P, Campo G, Anselmi M, Bolognese L, Colangelo S, Biondi-Zoccai G, et al. Multicenter Evaluation of Single High-Dose Bolus Tirofiban vs. Abciximab with Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study. Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction. EuroIntervention. 2012;8:71–8. CrossRefPubMed Vranckx P, Campo G, Anselmi M, Bolognese L, Colangelo S, Biondi-Zoccai G, et al. Multicenter Evaluation of Single High-Dose Bolus Tirofiban vs. Abciximab with Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study. Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction. EuroIntervention. 2012;8:71–8. CrossRefPubMed
13.
Zurück zum Zitat Rao SV, Cohen MG, Kandzari DE, Bertrand OF, Gilchrist IC. The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. J Am Collcardiol. 2010;55:2187–95. CrossRef Rao SV, Cohen MG, Kandzari DE, Bertrand OF, Gilchrist IC. The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. J Am Collcardiol. 2010;55:2187–95. CrossRef
14.
Zurück zum Zitat Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55:2556–66. CrossRefPubMed Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55:2556–66. CrossRefPubMed
15.
Zurück zum Zitat Bertrand OF, Patel T. Radial approach for primary percutaneous coronary intervention: ready for prime time? J Am Coll Cardiol. 2012;60:2500–3. CrossRefPubMed Bertrand OF, Patel T. Radial approach for primary percutaneous coronary intervention: ready for prime time? J Am Coll Cardiol. 2012;60:2500–3. CrossRefPubMed
16.
Zurück zum Zitat Lee MS, Wolfe M, Stone GW. Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence. JACC Cardiovasc Interv. 2013;6:1149–52. CrossRefPubMed Lee MS, Wolfe M, Stone GW. Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence. JACC Cardiovasc Interv. 2013;6:1149–52. CrossRefPubMed
17.
Zurück zum Zitat Bradley SM, Rao SV, Curtis JP, Parzynski CS, Messenger JC, Daugherty SL, et al. Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registry. Circ Cardiovasc Qual Outcomes. 2014;7:550–9. CrossRefPubMedPubMedCentral Bradley SM, Rao SV, Curtis JP, Parzynski CS, Messenger JC, Daugherty SL, et al. Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registry. Circ Cardiovasc Qual Outcomes. 2014;7:550–9. CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, ACUITY Investigators, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355:2203–16. CrossRefPubMed Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, ACUITY Investigators, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355:2203–16. CrossRefPubMed
19.
Zurück zum Zitat Baker NC, Escarcega RO, Lipinski MJ, Magalhaes MA, Koifman E, Kiramijyan S, et al. Active Versus Passive Anchoring Vascular Closure Devices Following Percutaneous Coronary Intervention: A Safety and Efficacy Comparative Analysis. J Interv Cardiol. 2016;29:108–12. CrossRefPubMed Baker NC, Escarcega RO, Lipinski MJ, Magalhaes MA, Koifman E, Kiramijyan S, et al. Active Versus Passive Anchoring Vascular Closure Devices Following Percutaneous Coronary Intervention: A Safety and Efficacy Comparative Analysis. J Interv Cardiol. 2016;29:108–12. CrossRefPubMed
20.
Zurück zum Zitat Yeni H, Axel M, Örnek A, Butz T, Maagh P, Plehn G. Clinical and Subclinical Femoral Vascular Complications after Deployment of two Different Vascular Closure Devices or Manual Compression in the Setting of Coronary Intervention. Int J Med Sci. 2016;13(4):255–9. CrossRefPubMedPubMedCentral Yeni H, Axel M, Örnek A, Butz T, Maagh P, Plehn G. Clinical and Subclinical Femoral Vascular Complications after Deployment of two Different Vascular Closure Devices or Manual Compression in the Setting of Coronary Intervention. Int J Med Sci. 2016;13(4):255–9. CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Hamon M, Pristipino C, Di Mario C, Nolan J, Ludwig J, Tubaro M, European Association of Percutaneous Cardiovascular Interventions, Working Group on Acute Cardiac Care of the European Society of Cardiology, Working Group on Thrombosis on the European Society of Cardiology, et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology. EuroIntervention. 2013;8:1242–51. CrossRefPubMed Hamon M, Pristipino C, Di Mario C, Nolan J, Ludwig J, Tubaro M, European Association of Percutaneous Cardiovascular Interventions, Working Group on Acute Cardiac Care of the European Society of Cardiology, Working Group on Thrombosis on the European Society of Cardiology, et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology. EuroIntervention. 2013;8:1242–51. CrossRefPubMed
Metadaten
Titel
Radial versus femoral access site for percutaneous coronary intervention in patients suffering acute myocardial infarction
A randomized prospective multicenter trial
verfasst von
MD Christiana Schernthaner
MD Matthias Hammerer
MD Stefan Harb
MD Matthias Heigert
MD Kurt Hoellinger
Elisabeth Lassnig
MD Edwin Maurer
MD Jochen Schuler
MD Peter Siostrzonek
MD Hanno Ulmer
MD Andreas Winter
MD Johann Altenberger
Publikationsdatum
12.09.2017
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 5-6/2018
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-017-1260-5